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 Coronary CT Angiography (CCTA) has been widely used as a reliable non-invasive 
modality for the diagnosis of Coronary Artery Disease (CAD) due to its improved spatial and 
temporal resolution.1-5 For patients with low to intermediate pre-test probability of CAD, CCTA 
is used as an effective gatekeeper for determination of downstream testing, such as invasive 
coronary angiography or functional imaging.6 However, CCTA is mainly an anatomic test with 
excellent visualization of coronary anatomical structures and detection of coronary lumen ste-
nosis, while providing little functional information of the coronary lesions. Despite high sensi-
tivity and negative predictive value, CCTA has been reported to have moderate specificity and 
positive predictive value due to the high percentage of false positive rates, and this is especially 
apparent in the assessment of coronary arteries with heavy calcification. Studies have shown 
the limited diagnostic value of CCTA in diagnosing highly calcified coronary plaques.7-11 Thus, 
an imaging technique able to detect ischemia-producing lesions is of paramount importance 
since coronary stenosis does not always translate to functional significance. Clinical decision 
making of whether patients should proceed to a revascularization procedure is based on the 
predictive functional effect of coronary stenosis, because no prognostic benefit of revascular-
ization has been reported in the coronary lesions without functional significance.12,13
 In recent years, a great interest has been shown in the investigation of diagnostic 
performance of non-invasive Fractional Flow Reserve derived from coronary CT angiography 
(FFRCT). The scientific basis for non-invasive quantification of FFRCT has been well described 
in the literature.14 FFRCT is computed by performing computational fluid dynamics modelling 
after image segmentation of coronary arteries and ascending aorta. The invasive FFR technique 
is conducted by using a pressure catheter to assess the rate of maximal myocardial blood flow 
through a coronary stenotic lesion in relation to the flow through the normal aorta in a hyper-
emic state.15-17 The FFR is a lesion-specific technique and is widely used as the reference test 
for assessment of the functional significance of a coronary stenosis. According to the Fractional 
Flow reserve versus angiography for multivessel evaluation (FAME) trials, FFR-guided percu-
taneous coronary intervention has been shown to result in lower rate of major adverse cardiac 
events when compared to visual estimation from invasive coronary angiography or best avail-
able medical therapy alone.18,19 However, invasive FFR is rarely performed in clinical practice, 
thus, a non-invasive method combining both anatomic and functional data to determine the 
hemodynamic significance of coronary lesions could serve as an alternative to invasive FFR for 
improvement of patient care and clinical outcomes.
 In the PLATFORM prospective multicentre trial, Douglas, et al. compared the clinical 
outcomes of symptomatic patients with an intermediate likelihood of obstructive CAD, who 
were assigned to undergo either the planned usual care testing or CCTA/FFRCT testing.
20 A 
total of 584 patients were recruited from 11 clinical sites with 287 receiving usual testing and 
297 receiving CCTA/FFRCT testing. The 90-day follow-up visits were reported in this study to 
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determine the cardiac event rates. The authors reported that non-obstructive CAD was found at Invasive Coronary Angiography 
(ICA) in 73% of the patients in the usual care group with intended ICA. In contrast, non-obstructive CAD was found at ICA in 12% 
of the patients in the CCTA/FFRCT group, which is significantly lower than that observed in the usual care group (p<0.0001) (Figure 
1). Among those with planned non-invasive testing, no significant difference was found in the rates of non-obstructive CAD at ICA 
between the two groups (6.0 usual care vs. 12.5% CCTA/FFRCT, p=0.95) (Figure 1). There were no significant differences in cardiac 
events between these two groups. The authors concluded that use of CCTA/FFRCT can be more effectively triage patients than the 
use care approach for invasive procedures since ICA was cancelled in 61% patients based on the results of CCTA/FFRCT.
 
 There are 2 observations from Douglas’s study that bear discussion. First, improved diagnostic strategy has been achieved 
in patient managements based on analysis of CCTA/FFRCT, with a significantly low rate of ICA showing non-obstructive CAD. 
This further verifies the advantage of FFRCT over CCTA in the diagnostic assessment of coronary stenosis. According to a recently 
published randomized controlled PROMISE trial, coronary CTA was found to increase the rate of invasive catheterization by 50% 
compared with functional testing.21 Clinical value of FFRCT in comparison with CCTA has been reported in three multicenter tri-
als, Diagnosis of Ischemia-Causing Coronary Stenoses by Non-invasive FFR Computed from Coronary Computed Tomographic 
Angiograms (DISCOVER-FLOW), Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography 
(DeFACTO), and NeXtsTeps (NXT) trials.22-24 Findings of these trials confirm that FFRCT is superior to CCTA for the diagnosis of 
ischemia-causing lesions on both per-patient and per-vessel analysis as determined by an invasive FFR the reference standard. Table 
1 shows the diagnostic value of FFRCT versus CCTA in stable patients with suspected CAD based on the analysis of these three trials.
Figure 1: Determination of the rate of invasive catheterization without obstructive coronary artery disease. NI: Non-invasive; ICA: Invasive 
Coronary Angiography; Obs CAD: Obstructive Coronary Artery Disease; FFRCT: Computation of fractional flow reserve from coronary 
computed tomographic angiography data.20
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 Second, ICA examination is associated with high rate of non-obstructive CAD as shown in Figure 1. Although physicians’ 
angiographic interpretation of coronary stenosis has been reported to have substantial disagreement from quantitative coronary an-
giographic images,25,26 the visual readings in Douglas’s study were low (57%) as the findings of determining non-obstructive CAD in 
ICA patients were determined by quantitative coronary angiography. This further highlights the limitation of ICA as an anatomic test 
or a luminogram. The role of ICA is gradually diminishing as compared to other imaging modalities such as CCTA or intravascular 
ultrasound,27,28 which are able to look beyond the lumen and characterize plaque morphology or vessel wall, thus, enabling detection 
of vulnerable coronary plaques responsible for development of adverse cardiac events. ICA remains the gold standard for the detec-
tion of coronary stenosis, however, according to the PROSPECT, the largest prospective study to investigate the natural history of 
CAD,29 the majority of non-culprit lesions responsible for acute coronary syndrome at a median follow-up of 3.4 years were mild 
lesions with diameter stenosis of 32% at baseline angiographic examination. Therefore, combining anatomic with functional imag-
ing modalities represents a future direction for determination of functional significance of coronary lesions.
 In summary, the PLATFORM trial adds additional value to other two recently published randomized controlled trials 
involving diagnostic performance of CCTA in CAD, the PROMISE and SCOT-HEART trials.21,30 Like all large multicenter trials, 
PLATFORM has limitations. It is not a randomized controlled trial. Further, the sample size and short follow-up period (90 days) 
make it difficult to detect the impact on clinical outcomes. Further studies with inclusion of a large cohort at longer follow-up peri-
ods are warranted.
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